Catalog No.
DVV03802
Host species
Homo sapiens
Species reactivity
Influenza A virus
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1, kappa
Applications
Research Grade Biosimilar
Target
HA/Hemagglutinin
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P03455
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
CT-P22, CAS: 1443004-15-6, Influenza Virus (Flu)
Note
For research use only. Not suitable for clinical or therapeutic use.
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome, PMID: 30001986
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies, PMID: 29707140
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies, PMID: 32601377
High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals, PMID: 28723950
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma, PMID: 30828910
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies, PMID: 24326534
How to outsmart NK cell tolerance, PMID: 26405590
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy, PMID: 24701370